HP Vitaran i is the eye-area polynucleotide booster of BR Pharm’s Vitaran range: 20 mg of polynucleotide sodium (2%) per 1 mL prefilled syringe, two per box with 34G needles, formulated at the lowest viscosity of the range for thin periorbital skin. It shares Vitaran PN’s Korean MFDS Class IV medical-device approval and CE mark, contains no lidocaine and is stored at 1–30 °C. Professional use only.
What is HP Vitaran i?
HP Vitaran i is the eye-area member of BR Pharm’s Vitaran polynucleotide range. It contains the same 20 mg/mL polynucleotide sodium (2%) as Vitaran PN and shares its MFDS Class IV approval and CE mark, but is formulated at the lowest viscosity of the range and supplied with an ultra-fine 34G/4 mm needle, so it spreads easily in the thin skin around the eyes. Two 1 mL prefilled syringes per box, no lidocaine.
How does Vitaran i compare with other eye-area PN boosters?
Lyderma stocks several polynucleotide options for the periorbital zone. Vitaran i is the one that combines a full 2% PN concentration with device-level MFDS approval. Rejuran I is PharmaResearch’s 1 mL eye formula; AMI Eyes offers 1% PN in 2 mL; Puri Eyes is the gentlest at 2 mg/mL.
| HP Vitaran i | PN 20 mg/mL · 2 × 1 mL · lowest viscosity · 34G · MFDS Class IV |
|---|---|
| HP Vitaran PN | PN 20 mg/mL · 2 × 1 mL · mid viscosity · 33G |
| Rejuran I | Low-viscosity PN · 1 × 1 mL · eye area |
| AMI Eyes | PN 1% · 1 × 2 mL · eye area |
What do clinics use Vitaran i for?
It is commonly selected for crow’s feet, under-eye fine lines and crepey periorbital skin — the labelled indication being crow’s-feet fine wrinkles in adults — and wherever a very fine needle and low-viscosity PN are preferred on thin skin. BR Pharm does not publish a session protocol; the treating clinician decides number and spacing of sessions and assesses suitability.
Commonly selected for
- Under-eye and crow’s-feet fine lines
- Thin, delicate facial skin
- Practices that require MFDS device approval and CE marking
- Pairing with Vitaran PN for full-face plus eye courses
How is Vitaran i supplied and stored?
Two 1 mL prefilled syringes per box with 34G/4 mm needles. Store at 1–30 °C protected from light; shelf life three years from manufacture.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | HP Vitaran® i (BR Pharm) |
|---|---|
| Manufacturer | BR PHARM Co., Ltd. (Wonju, South Korea) |
| Origin | South Korea |
| Active | Polynucleotide sodium 20 mg/mL (2%) |
| Composition | Polynucleotide sodium 20 mg per 1 mL prefilled syringe; no lidocaine |
| Format | 1 mL prefilled syringe |
| Presentation | 2 prefilled syringes per box; 34G / 4 mm needle |
| Areas | Eye area · thin facial skin |
| Viscosity | Lowest (●) of the Vitaran range |
| Regulatory | Korea MFDS-approved Class IV medical device (approval 제허 23-784호) · CE-marked |
| Administration | Intradermal injection — by a qualified medical professional only |
| Storage & handling | 1–30 °C, protected from light; shelf life 3 years (manufacturer) |
Frequently asked questions
What is Vitaran i used for?
For crow’s feet, under-eye fine lines and crepey periorbital skin — its MFDS-labelled indication is crow’s-feet fine wrinkles in adults.
Is the PN concentration lower than Vitaran PN?
No. Both contain 20 mg/mL (2%) polynucleotide sodium. Vitaran i differs by its lower viscosity and finer 34G needle.
Is Vitaran i approved?
Yes — Korea MFDS-approved Class IV medical device (approval 제허 23-784호) and CE-marked, per the manufacturer. No U.S. FDA approval.
How does it compare with Rejuran I?
Both are low-viscosity PN products for the eye area. Vitaran i supplies 2% PN in two 1 mL syringes with device-level MFDS approval; Rejuran I is PharmaResearch’s single 1 mL eye syringe.
How should it be stored?
At 1–30 °C protected from light; three-year shelf life. Two 1 mL syringes per box.